Evidence map›Paper›PMID 10376967›Full record

ArticleBritish journal of cancer1999

Differentiation of human colon cancer cells changes the expression of beta-tubulin isotypes and MAPs.

G Carles, D Braguer, C Dumontet, V Bourgarel, A Gonçalves, M Sarrazin, J B Rognoni, C Briand

Open access · hybridAbstract read
In one paragraph

Article in British journal of cancer, 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 57 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Differential expression of glu-tubulin in relation to mammary gland disease.Virchows Archiv : an international journal of pathology · 2010
    Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Resistance to Taxol in lung cancer cells associated with increased microtubule dynamics.Proceedings of the National Academy of Sciences of the United States of America · 2001
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

G CarlesUPRES-A CNRS 6032, University of la Méditerranée, Faculty of Pharmacy, Marseille, France.
D Braguer
C Dumontet
V Bourgarel
A Gonçalves
M Sarrazin
J B Rognoni
C Briand
Centre National de la Recherche Scientifique · FRInstitut de Neurobiologie de la Méditerranée · FRInstitut des Sciences Analytiques · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The human colon adenocarcinoma HT29-D4 cell line is an interesting model for studies on epithelial cell differentiation. Undifferentiated cells are malignant proliferating cells, whereas differentiated cells act like epithelial polarized cells. In the present study, we first characterized the action of taxoids on the microtubular network of HT29-D4 cells according to the state of differentiation. Microtubular bundles were found in undifferentiated cells but not in differentiated cells, even with 500-fold higher taxoid concentrations for 96 h. This finding led us to study changes in microtubules according to the polarity status of the cell. E-MAP-115 was expressed only in differentiated cells; expression of beta-tubulin isotypes was altered in them relative to undifferentiated cells. Classes I, II, III, IVa and IVb isotypes were expressed in both phenotypes; however, differentiated epithelial cells displayed a specific increase in class III beta-tubulin. Thus, the increase in expression of this beta-tubulin isotype in differentiated cells is not restricted to neuronal cells. Moreover, these expression changes may reflect a higher stability of microtubular network in differentiated cells, which may explain the lower activity of anti-microtubule agents, independently of the mitotic process. These results indicate that the composition of microtubules should be considered as one of the criteria involved in the response of tumour cells to chemotherapy with anti-microtubule agents.

Indexed as

Cell DifferentiationCell Transformation, NeoplasticAntineoplastic Agents, PhytogenicHT29 CellsHumansMicrotubule-Associated ProteinsMicrotubulesMolecular Sequence DataPaclitaxelReverse Transcriptase Polymerase Chain ReactionRNATubulinAntineoplastic Agents, PhytogenicMicrotubule-Associated ProteinsPaclitaxelRNATubulin

Identifiers

PMID10376967
PMCPMC2362354
OpenAlexW1976300798

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.